MedDataX Logo

Determination of the Glycemic Index Values of 10 Cereal-based Products

NCT ID: NCT06710743

Last Updated: 2024-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2024-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the Glycemic index values for 10 cereal-based products

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine the Glycemic index values for 10 cereal-based products per international standard (ISO26642:2010) for glycemic index determination.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Glycemic Index (GI) Food Pre Diabetes Diabetes

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Low GI food glycemic index cereal carbohydrate glucose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reference food

Glucodin powder solution

Group Type ACTIVE_COMPARATOR

Glucose solution Day 1, Day 8, and Day 15

Intervention Type OTHER

Glucodin powder diluted with water

Food 1

Quaker Whole Oats

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 2

Quaker Quick Cooking White Oats

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 3

Saffola Oats

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 4

Quaker Oats

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 5

Quaker Oats Multigrain

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 6

Ragi Flakes

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 7

Bajra Flakes

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 8

Jowar Flakes

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 9

Maltabella

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Food 10

FutureLife Smart + White Oats

Group Type EXPERIMENTAL

Food (cereal). Ten different cereals served once each

Intervention Type OTHER

Variety of cooked or flake cereal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glucose solution Day 1, Day 8, and Day 15

Glucodin powder diluted with water

Intervention Type OTHER

Food (cereal). Ten different cereals served once each

Variety of cooked or flake cereal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y
* BMI: 18 - 25.0 kg/m2 (bounds included)
* Non smokers
* Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting \<6 mM, 2 hr glucose \<7.8 mM)
* Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting
* Normal sleep patterns (ie. at least 6 hours of sleep per night)
* The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session.
* Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion Criteria

* Food allergy or intolerance to the study ingredients (eg. gluten, etc.)
* Regularly taking prescription medication other than standard contraceptive medication
* Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis)
* Suffering from any illness or disease
* Following a restricted diet
* Smokers
* Eating disorders
* Abnormal glucose tolerance or known history of diabetes mellitus.
* Individuals currently participating in other acute metabolic studies
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richa Bharti, MS

Role: PRINCIPAL_INVESTIGATOR

PepsiCo R&D Life Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sydney University's Glycemic Index Research Service (SUGiRS)

Sydney, New South Wales, Australia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP-2402

Identifier Type: -

Identifier Source: org_study_id